Zampieri, Fernando G. http://orcid.org/0000-0001-9315-6386
,
Salluh, Jorge I. F.
Azevedo, Luciano C. P.
Kahn, Jeremy M.
Damiani, Lucas P.
Borges, Lunna P.
Viana, William N.
Costa, Roberto
Corrêa, Thiago D.
Araya, Dieter E. S.
Maia, Marcelo O.
Ferez, Marcus A.
Carvalho, Alexandre G. R.
Knibel, Marcos F.
Melo, Ulisses O.
Santino, Marcelo S.
Lisboa, Thiago
Caser, Eliana B.
Besen, Bruno A. M. P.
Bozza, Fernando A.
Angus, Derek C.
Soares, Marcio
Funding for this research was provided by:
FAPERJ
Article History
Received: 4 July 2019
Accepted: 17 September 2019
First Online: 8 October 2019
Compliance with ethical standards
:
: JIFS and MS are founders and proprietors of Epimed Solutions<sup>®</sup>. LPB is an employee of Epimed Solutions<sup>®</sup>. FGZ has received grant for an investigator-initiated clinical trial from Bactiguard<sup>®</sup>, Sweden, which is unrelated to the aspects of this work. The other authors report no conflicts of interest to declare.